83 related articles for article (PubMed ID: 18768351)
21. Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up.
Verhaert D; Grimm RA; Puntawangkoon C; Wolski K; De S; Wilkoff BL; Starling RC; Tang WH; Thomas JD; Popović ZB
J Am Coll Cardiol; 2010 Apr; 55(17):1788-95. PubMed ID: 20413027
[TBL] [Abstract][Full Text] [Related]
22. Pathobiology of left ventricular dyssynchrony and resynchronization.
Spragg DD; Kass DA
Prog Cardiovasc Dis; 2006; 49(1):26-41. PubMed ID: 16867848
[TBL] [Abstract][Full Text] [Related]
23. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure.
Valzania C; Gadler F; Eriksson MJ; Olsson A; Boriani G; Braunschweig F
Eur J Heart Fail; 2007; 9(6-7):644-50. PubMed ID: 17347041
[TBL] [Abstract][Full Text] [Related]
24. Echo Doppler parameters predict response to cardiac resynchronization therapy.
Wiesbauer F; Baytaroglu C; Azar D; Blessberger H; Goliasch G; Graf S; Mundigler G; Pacher R; Maurer G; Binder T
Eur J Clin Invest; 2009 Jan; 39(1):1-10. PubMed ID: 19087125
[TBL] [Abstract][Full Text] [Related]
25. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling: a circumferential strain analysis based on 2D echocardiography.
Song ZZ
Eur Heart J; 2008 Mar; 29(5):684; author reply 684-5. PubMed ID: 18263870
[No Abstract] [Full Text] [Related]
26. Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias.
Kiès P; Bax JJ; Molhoek SG; Bleeker GB; Zeppenfeld K; Bootsma M; St John Sutton M; van Erven L; van der Wall EE; Schalij MJ
Am J Cardiol; 2004 Jul; 94(1):130-2. PubMed ID: 15219525
[TBL] [Abstract][Full Text] [Related]
27. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
[TBL] [Abstract][Full Text] [Related]
28. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
[TBL] [Abstract][Full Text] [Related]
29. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
30. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
31. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy.
Di Biase L; Auricchio A; Sorgente A; Civello K; Klersy C; Faletra F; Riedlbauchova L; Patel D; Arruda M; Schweikert RA; Martin DO; Saliba WI; Moccetti T; Wilkoff BL; Natale A
Eur Heart J; 2008 Oct; 29(20):2497-505. PubMed ID: 18515806
[TBL] [Abstract][Full Text] [Related]
32. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
Ypenburg C; Sieders A; Bleeker GB; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
Am Heart J; 2007 Dec; 154(6):1160-5. PubMed ID: 18035090
[TBL] [Abstract][Full Text] [Related]
33. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
[TBL] [Abstract][Full Text] [Related]
34. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy.
Iyengar S; Haas G; Lamba S; Orsinelli DA; Babu GJ; Ferketich AK; Yamokoski L; Periasamy M; Abraham WT
J Card Fail; 2007 May; 13(4):304-11. PubMed ID: 17517351
[TBL] [Abstract][Full Text] [Related]
35. Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium.
D'Ascia C; Cittadini A; Monti MG; Riccio G; Saccà L
Eur Heart J; 2006 Jan; 27(2):201-6. PubMed ID: 16291773
[TBL] [Abstract][Full Text] [Related]
36. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?
Yu CM; Zhang Q; Yip GW; Chan YS; Lee PW; Wu LW; Lam YY; Kum LC; Chan HC; Chan S; Fung JW
Am J Cardiol; 2006 Oct; 98(8):1083-7. PubMed ID: 17027576
[TBL] [Abstract][Full Text] [Related]
37. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin.
Francia P; Salvati A; Balla C; De Paolis P; Pagannone E; Borro M; Gentile G; Simmaco M; De Biase L; Volpe M
Eur J Heart Fail; 2007 Mar; 9(3):306-9. PubMed ID: 16891152
[TBL] [Abstract][Full Text] [Related]
38. Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism.
van der Wall EE; Schalij MJ; van der Laarse A; Bax JJ
Int J Cardiovasc Imaging; 2010 Mar; 26(3):293-7. PubMed ID: 20148366
[No Abstract] [Full Text] [Related]
39. Biochemical markers of myocardial remodelling in hypertensive heart disease.
González A; López B; Ravassa S; Beaumont J; Arias T; Hermida N; Zudaire A; Díez J
Cardiovasc Res; 2009 Feb; 81(3):509-18. PubMed ID: 18762556
[TBL] [Abstract][Full Text] [Related]
40. Selenium contributes to myocardial injury and cardiac remodeling in heart failure.
Alexanian I; Parissis J; Farmakis D; Pantziou C; Ikonomidis I; Paraskevaidis I; Ioannidou S; Sideris A; Kremastinos D; Lekakis J; Filippatos G
Int J Cardiol; 2014 Sep; 176(1):272-3. PubMed ID: 25042657
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
